Mpox, Project Bioshield: Everyone’s Dark Winter?

 In 2022, mpox (formerly known as monkey pox) drew worldwide attention, when more than 20 countries reported infections to the World Health Organization by May of that year. It led to WHO Director-General, Tedros Adhanom Ghebreyesus, declaring the mpox outbreak involving clade IIb of the virus in the Democratic Republic of the Congo and its expansion to neighbouring countries, a global health emergency.

The monkeypox virus is part of the same family of viruses (orthopoxviruses) as smallpox but is less severe. In 1980, the World Health Assembly announced that smallpox had been eradicated and recommended that all countries cease vaccination. Although labs in two countries still officially store smallpox samples (US and Russia).

Mpox was first identified in Denmark, in 1958, when two outbreaks of a pox-like disease occurred in lab monkeys, which is how it got its name – although monkeys are not considered to be reservoirs for the virus. The source of the virus is said to be unknown.

In 1970, the first human case of mpox was recorded in the Democratic Republic of the Congo. This was during a time when smallpox was being eradicated. The disease is considered to be endemic to countries in central and west Africa. The outbreaks have been concentrated among men who have sex with men.

In late September 2023, the emergence of a new variant of the virus was detected in central Africa. As of August 2024, more than 21,000 cases have been reported, with over 600 fatalities, nearly all in the Democratic Republic of the Congo.

On 14 August 2024, the World Health Organization declared the epidemic a public health emergency of international concern (PHEIC).

A month after the WHO’s announcement, the small Danish biotech firm, Bavarian Nordic, became the first in the world to receive approval for a monkeypox vaccine, JYNNEOS (known internationally as Imvamune or Imvanex), initially developed for smallpox but was rarely used.

In the wake of the September 2001 anthrax attacks, President George W. Bush signed into law the Project BioShield Act of 2004 (Project BioShield) “as part of a broader strategy to defend America against the threat of weapons of mass destruction. The purpose of Project BioShield is to accelerate the research, development, purchase, and availability of effective medical countermeasures against biological, chemical, radiological, and nuclear (CBRN) threats.”

Project Bioshield was a ten-year program managed by Biomedical Advanced Research and Development Authority (BARDA), part of the United States Department of Health and Human Services (HHS).

The act called for $5 billion for purchasing vaccines that would be used in the event of a bioterrorist attack, for civilian use. Since 2001, $50 billion has been allocated by the United States government to address the threat of biological weapons....<<<Read More>>>...

Australian Senator Malcolm Roberts: The time of blind trust in WHO’s narrative is over; it’s now the age of “prove it”

 Its NOT in mainstream media but the crooked Tedros Adhanom Ghebreyesus of the sinister WHO recently announced that Mpox isn't as much a danger as they previously made out. Seriously, keeping this truth from the mainstream media suggests that fear narratives are the planned form of terrorism .....

+++++++++++++++++++++++++++

Malcolm Roberts, Senator for Queensland, has delivered a speech in the Australian about the World Health Organisation declaring monkeypox (now mpox) a global public health emergency.

WHO is influenced by big pharmaceutical companies, he told the Chamber, it lacks transparency in its dealings and there is conflict of interest with vaccine sales. WHO is a corrupt organisation and its director-general, Tedros Adhanom Ghebreyesus, has unchecked power.

In the recent past, both WHO and the Therapeutic Goods Administration have failed in their regulatory duties, serving political agendas rather than the public interest. The time of blind trust in the WHO’s narrative is over; it’s now the age of “prove it,” he said.

In a speech in the Australian Senate on 20 August Senator Malcolm Roberts addressed the recently declared public health emergency of international concern (“PHEIC”) for mpox. The following is a synopsis followed by a recording of his speech.

The World Health Organisation (“WHO”) has declared monkeypox a global public health emergency, triggering emergency powers to drive vaccine sales that benefit big pharmaceutical companies with ties to the organisation. This decision serves corporate interests rather than public health.

Regulatory agencies that are meant to protect the public fall under undue influence from the industries they regulate. The WHO is a corrupt organisation that is designed to funnel taxpayer money to its billionaire donors. Australian taxpayers gave $30 million to the WHO last year, likely as a show of loyalty.

Transparency is lacking. Major donors include GAVI, a vaccine alliance funded by corporations tied to predatory giants like BlackRock and Vanguard, who also own large shares in pharmaceutical companies.

The WHO’s monkeypox emergency, declared solely by its director-general, Tedros Ghebreyesus, highlights the unchecked power of the position. This decision created a market for four already-approved vaccines linked to companies backed by BlackRock and Vanguard, ensuring massive profits for their shareholders. A new monkeypox vaccine is expected soon, likely fast-tracked by compromised regulators like Australia’s Therapeutic Goods Administration (“TGA”).

The WHO previously tried to raise alarm over monkeypox but found little public concern, so they rebranded it as “mpox” to push vaccine sales. This benefits the predatory billionaires who control vaccine companies, funnel money to GAVI and the WHO, and fund political parties, including Australia’s Liberal and Labor parties....<<<Read More>>>....

WHO wants money to implement its regional plan for its PHEIC (“fake”) declaration for mpox

 The World Health Organisation’s recent declaration of a mpox (aka monkeypox) public health emergency of international concern (“PHEIC”) allows for the extension of recommendations from the previously declared mpox PHEIC in 2022 and the issuance of new ones, along with facilitating the granting of emergency use listings for monkeypox vaccines.

To implement its mpox response plan for the affected region in Africa, WHO is, initially, asking for donors and funders to provide it with US$15 million. This is in addition to direct aid from countries. For example, the US has committed hundreds of millions of dollars in aid, primarily for vaccines, to the DRC which is at the epicentre of the outbreak.

These developments come while there are ongoing discussions about a Pandemic Treaty, which WHO is hoping will pass shortly...<<<Read More>>>...